Tobradex and Acyclovir drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Tobradex (dexamethasone; tobramycin) and Acyclovir (acyclovir). Common drug interactions include skin hyperpigmentation among females and anaemia among males.
The phase IV clinical study analyzes what interactions people have when they take Tobradex and Acyclovir. It is created by eHealthMe based on reports of 66 people who take the same drugs from the FDA, and is updated regularly.
What is Tobradex?
Tobradex has active ingredients of dexamethasone; tobramycin. It is often used in eye infection. eHealthMe is studying from 3,154 Tobradex users. Check the latest studies of Tobradex.
What is Acyclovir?
Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.
66 people who take Tobradex and Acyclovir together, and have interactions are studied.

What are the common drug interactions of Tobradex and Acyclovir, by gender? *:
female:
- Skin hyperpigmentation (disorders affect the colour of your skin)
- Skin hypertrophy (skin cells enlarges)
- Skin induration (an abnormally hard spot or area on the skin)
- Skin tightness
- Chest pain
- Headache (pain in head)
- Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Drug hypersensitivity
- Dyspnoea (difficult or laboured respiration)
male:
- Anaemia (lack of blood)
- Anxiety
- Azotaemia (excess of urea or other nitrogenous compounds in the blood)
- Bone disorder
- Fistula (an abnormal connection or passageway between two)
- Gingivitis (inflammation of gums)
- Hepatomegaly (abnormal enlargement of the liver)
- Infection
- Injury
- Osteitis (a general term for inflammation of bone)
What are the common drug interactions of Tobradex and Acyclovir, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
10-19:
- Corneal exfoliation (removal of the oldest dead cells of outer most layer of cornea)
20-29:
n/a
30-39:
- Pain
- Abortion (termination of pregnancy)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Bronchitis acute (acute inflammation of the mucous membrane in the bronchial tubes)
- Chest pain
- Chest tightness
- Complications of maternal exposure to therapeutic drugs
- Depression
- Drug dependence
40-49:
- Conjunctival hyperaemia (congestion of conjunctival vessels)
- Eye inflammation
- Hypertension (high blood pressure)
- Hypopyon (pus in the eye)
- Metastases to heart (cancer spreads to heart)
- Metastases to lung (cancer spreads to lung)
- Neuropathy peripheral (surface nerve damage)
- Pneumonia
- Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
- Ulcerative keratitis (ulcerative inflammation of the cornea)
50-59:
- Coronary artery stenosis (narrowing of coronary artery)
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Cytomegalovirus hepatitis (virus infection of liver)
- Decreased activity
- Deformity (disfigurement)
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Dry mouth
- Dysphonia (speech disorder attributable to a disorder of phonation)
- Dyspnoea (difficult or laboured respiration)
- Electrocardiogram poor r-wave progression
60+:
- Pain
- Injury
- Fistula (an abnormal connection or passageway between two)
- Gingivitis (inflammation of gums)
- Hepatomegaly (abnormal enlargement of the liver)
- Infection
- Osteitis (a general term for inflammation of bone)
- Skin lesion
- Swelling
- Tooth abscess (pus formation in tooth)
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 9 people, 13.64%
- High Blood Pressure: 5 people, 7.58%
- Conjunctivitis (pink eye): 5 people, 7.58%
* Approximation only. Some reports may have incomplete information.
Do you take Tobradex and Acyclovir?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Tobradex and Acyclovir:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tobradex:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Acyclovir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tobradex and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Acyclovir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Choi N, Lee JY, Sunwoo JS, Kwon KI, Roh H, Ahn MY, Lee KB, "Hyponatremia during Acyclovir Treatment of Bell’s Palsy", Journal of the Korean Neurological Association, 2017 Aug .
- Choi N, Lee JY, Sunwoo JS, Kwon KI, Roh H, Ahn MY, Lee KB, "Hyponatremia during Acyclovir Treatment of Bell’s Palsy", Journal of the Korean Neurological Association, 2017 Aug .
How the study uses the data?
The study uses data from the FDA. It is based on dexamethasone; tobramycin and acyclovir (the active ingredients of Tobradex and Acyclovir, respectively), and Tobradex and Acyclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Metformin cause Vasculitis? - 22 seconds ago
- Could Aciphex cause Haemangioma? - 35 seconds ago
- Could Lortab cause Skin Abscess? - 41 seconds ago
- Drug interactions of Spironolactone and Namenda - 50 seconds ago
- Could Darvocet cause Agitation? - 52 seconds ago
- Drug interactions of Abilify and Zanaflex - 55 seconds ago
- Chlor-Trimeton vs. Beconase, side effect and effectiveness comparison - a minute ago
- Could Simvastatin cause Brain Oedema? - a minute ago
- Drug interactions of Allegra and Flagyl - a minute ago
- Drug interactions of Effexor and Armodafinil - a minute ago